dniven_a_professional_minimalist_photo_realistic_image_of_a_sty_773c2d35-49b4-4205-adfd-38

Clearer strategy for access, portfolio and commercial decisions

Niven Biopharma supports biopharma, healthcare organisations, and specialist service providers in turning complex access, portfolio, and commercial challenges into clear, actionable plans that help treatments reach patients.

DISCUSS YOUR CHALLENGE

EXPLORE SERVICES

When to work with Niven Biopharma

When you need senior, objective support to work through a complex strategic problem, prepare for a significant investment or business decision, or bring a clearer external market perspective to internal planning.

dniven_a_professional_minimalist_photo_realistic_image_of_a_s_c610be29-5a97-467f-a3e2-b5d8

What we do

Market Access Strategy

Helping organisations understand value, evidence, payer needs, and routes to access.

MORE INFO

Commercial Strategy

Supporting clearer market, customer, and growth decisions.

MORE INFO

Portfolio Strategy

Helping teams assess opportunities, prioritise assets, and make confident strategic choices.

MORE INFO

Why Niven Biopharma?

✔ Senior experience,

✔ Clear strategic thinking

✔ The ability to bring diverse perspectives together into practical action.

dniven_a_professional_minimalist_photo_realistic_image_of_a_sty_7f01bead-a759-4865-bc13-d0

Example projects

Recent work has supported strategic decisions across market access, healthcare services, go-to-market planning and portfolio direction.

Global market access landscape and indication strategy
Developed a global market access landscape across 10+ countries for a biotech evaluating two potential therapeutic indications. The work combined secondary research, stakeholder interviews and quantitative research to assess access opportunity, pricing corridor, payer expectations and market viability. Findings were used to inform pivotal trial design and portfolio strategy.

European cancer services growth strategy
Supported a European healthcare services company in developing its cancer strategy across public and private markets. Work included business strategy, end-to-end pathway design, customer engagement planning, and evidence generation. Outputs informed short- and long-term growth plans now being implemented across the business.

Business-to-business go-to-market strategy
Supported a medtech services company in assessing the opportunity to partner with biopharma and health system organisations. Work included market sizing, positioning development and primary market research to evaluate customer needs and commercial potential. Outputs informed go-to-market strategy and supported ongoing business development discussions.